1.2.276.0.76.3.1.131.1.11.132/static-2015-12-08T000000: Unterschied zwischen den Versionen

Aus Hl7wiki
Wechseln zu: Navigation, Suche
(Automated ADBot page content)
 
(Automated ADBot page content)
 
Zeile 1: Zeile 1:
  
<table xmlns="http://www.w3.org/1999/xhtml" class="artdecor" border="0" cellspacing="10" style="background: transparent;"><tr><td xmlns="" class="tabtab"><table xmlns="http://www.w3.org/1999/xhtml" class="artdecor" width="100%" border="0" cellspacing="3" cellpadding="2" style="background: transparent;"><tr style="vertical-align: top;"><th style="vertical-align: top;" colspan="4">Beschreibung</th></tr><tr><td xmlns="" colspan="4">Applikationsart</td></tr><tr class="headinglabel"><th style="text-align: left;">Value Set Name</th><th style="text-align: left;">Value Set Id</th><th style="text-align: left;">Version / Eingangsdatum</th><th style="text-align: left;">Status</th></tr><tr style="background-color: #F6F3EE;"><td xmlns=""><i xmlns="http://www.w3.org/1999/xhtml">ApplArt</i></td><td xmlns="">1.2.276.0.76.3.1.131.1.11.132</td><td xmlns="">2015‑12‑08</td><td xmlns="">Entwurf</td></tr><tr><td xmlns="">Quell-Codesystem:<ul xmlns="http://www.w3.org/1999/xhtml"><li>1.2.276.0.76.3.1.131.1.5.132</li></ul></td></tr><tr><td xmlns="" colspan="4"><table xmlns="http://www.w3.org/1999/xhtml" class="artdecor" width="100%" border="0" cellspacing="3" cellpadding="2" style="background: transparent;"><tr style="background-color: #F6F3EE;"><td xmlns="" style="width: 100px; text-align: left;">Level/ Typ</td><td xmlns="" style="width: 100px; text-align: left;">Code</td><td xmlns="" style="text-align: left;">Anzeigename</td><td xmlns="" style="width: 200px; text-align: left;">Codesystem</td><td xmlns="" style="vertical-align: top; text-align: left;">Beschreibung</td></tr><tr><td xmlns="" style="vertical-align: top;">0-L</td><td xmlns="" style="vertical-align: top;"><strong xmlns="http://www.w3.org/1999/xhtml">P</strong></td><td xmlns="" style="vertical-align: top;">perkutan (Teletherapie)</td><td xmlns="" style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td xmlns="" style="vertical-align: top;"></td></tr><tr><td xmlns="" style="vertical-align: top;">0-L</td><td xmlns="" style="vertical-align: top;"><strong xmlns="http://www.w3.org/1999/xhtml">PRCJ</strong></td><td xmlns="" style="vertical-align: top;">Radiochemotherapie/Sensitizer: ja</td><td xmlns="" style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td xmlns="" style="vertical-align: top;"></td></tr><tr><td xmlns="" style="vertical-align: top;">0-L</td><td xmlns="" style="vertical-align: top;"><strong xmlns="http://www.w3.org/1999/xhtml">PRCN</strong></td><td xmlns="" style="vertical-align: top;">Radiochemotherapie/Sensitizer: nein</td><td xmlns="" style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td xmlns="" style="vertical-align: top;"></td></tr><tr><td xmlns="" style="vertical-align: top;">0-L</td><td xmlns="" style="vertical-align: top;"><strong xmlns="http://www.w3.org/1999/xhtml">K</strong></td><td xmlns="" style="vertical-align: top;">endokavitäre Kontakttherapie (Brachytherapie)</td><td xmlns="" style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td xmlns="" style="vertical-align: top;"></td></tr><tr><td xmlns="" style="vertical-align: top;">0-L</td><td xmlns="" style="vertical-align: top;"><strong xmlns="http://www.w3.org/1999/xhtml">KHDR</strong></td><td xmlns="" style="vertical-align: top;">K + high dose rate therapy</td><td xmlns="" style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td xmlns="" style="vertical-align: top;"></td></tr><tr><td xmlns="" style="vertical-align: top;">0-L</td><td xmlns="" style="vertical-align: top;"><strong xmlns="http://www.w3.org/1999/xhtml">KPDR</strong></td><td xmlns="" style="vertical-align: top;">K + pulsed dose rate therapy</td><td xmlns="" style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td xmlns="" style="vertical-align: top;"></td></tr><tr><td xmlns="" style="vertical-align: top;">0-L</td><td xmlns="" style="vertical-align: top;"><strong xmlns="http://www.w3.org/1999/xhtml">KLDR</strong></td><td xmlns="" style="vertical-align: top;">K + low dose rate therapy</td><td xmlns="" style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td xmlns="" style="vertical-align: top;"></td></tr><tr><td xmlns="" style="vertical-align: top;">0-L</td><td xmlns="" style="vertical-align: top;"><strong xmlns="http://www.w3.org/1999/xhtml">I</strong></td><td xmlns="" style="vertical-align: top;">interstitielle Kontakttherapie (Brachytherapie)</td><td xmlns="" style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td xmlns="" style="vertical-align: top;"></td></tr><tr><td xmlns="" style="vertical-align: top;">0-L</td><td xmlns="" style="vertical-align: top;"><strong xmlns="http://www.w3.org/1999/xhtml">IHDR</strong></td><td xmlns="" style="vertical-align: top;">I + high dose rate therapy</td><td xmlns="" style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td xmlns="" style="vertical-align: top;"></td></tr><tr><td xmlns="" style="vertical-align: top;">0-L</td><td xmlns="" style="vertical-align: top;"><strong xmlns="http://www.w3.org/1999/xhtml">IPDR</strong></td><td xmlns="" style="vertical-align: top;">I + pulsed dose rate therapy</td><td xmlns="" style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td xmlns="" style="vertical-align: top;"></td></tr><tr><td xmlns="" style="vertical-align: top;">0-L</td><td xmlns="" style="vertical-align: top;"><strong xmlns="http://www.w3.org/1999/xhtml">ILDR</strong></td><td xmlns="" style="vertical-align: top;">I + low dose rate therapy</td><td xmlns="" style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td xmlns="" style="vertical-align: top;"></td></tr><tr><td xmlns="" style="vertical-align: top;">0-L</td><td xmlns="" style="vertical-align: top;"><strong xmlns="http://www.w3.org/1999/xhtml">M</strong></td><td xmlns="" style="vertical-align: top;">metabolische Therapie (Radionuklide)</td><td xmlns="" style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td xmlns="" style="vertical-align: top;"></td></tr><tr><td xmlns="" style="vertical-align: top;">0-L</td><td xmlns="" style="vertical-align: top;"><strong xmlns="http://www.w3.org/1999/xhtml">MSIRT</strong></td><td xmlns="" style="vertical-align: top;">M + Selektive Interne Radio-Therapie</td><td xmlns="" style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td xmlns="" style="vertical-align: top;"></td></tr><tr><td xmlns="" style="vertical-align: top;">0-L</td><td xmlns="" style="vertical-align: top;"><strong xmlns="http://www.w3.org/1999/xhtml">MPRRT</strong></td><td xmlns="" style="vertical-align: top;">M + Peptid-Radio-Rezeptor-Therapie</td><td xmlns="" style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td xmlns="" style="vertical-align: top;"></td></tr><tr><td xmlns="" style="vertical-align: top;">0-L</td><td xmlns="" style="vertical-align: top;"><strong xmlns="http://www.w3.org/1999/xhtml">S</strong></td><td xmlns="" style="vertical-align: top;">Sonstiges</td><td xmlns="" style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td xmlns="" style="vertical-align: top;"></td></tr></table></td></tr><tr class="desclabel"><td xmlns="" colspan="4">Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors werden im @nullFlavor Attribut statt in @code angegeben.</td></tr></table></td></tr></table>
+
<table xmlns="http://www.w3.org/1999/xhtml" class="artdecor" border="0" cellspacing="10" style="background: transparent;"><tr><td class="tabtab"><table class="artdecor" width="100%" border="0" cellspacing="3" cellpadding="2" style="background: transparent;"><tr style="vertical-align: top;"><th style="vertical-align: top;" colspan="4">Beschreibung</th></tr><tr><td colspan="4">Applikationsart</td></tr><tr class="headinglabel"><th style="text-align: left;">Value Set Name</th><th style="text-align: left;">Value Set Id</th><th style="text-align: left;">Version / Eingangsdatum</th><th style="text-align: left;">Status</th></tr><tr style="background-color: #F6F3EE;"><td><i>ApplArt</i></td><td>1.2.276.0.76.3.1.131.1.11.132</td><td>2015‑12‑08</td><td>Entwurf</td></tr><tr><td>Quell-Codesystem:<ul><li>1.2.276.0.76.3.1.131.1.5.132</li></ul></td></tr><tr><td colspan="4"><table class="artdecor" width="100%" border="0" cellspacing="3" cellpadding="2" style="background: transparent;"><tr style="background-color: #F6F3EE;"><td style="width: 100px; text-align: left;">Level/ Typ</td><td style="width: 100px; text-align: left;">Code</td><td style="text-align: left;">Anzeigename</td><td style="width: 200px; text-align: left;">Codesystem</td><td style="vertical-align: top; text-align: left;">Beschreibung</td></tr><tr><td style="vertical-align: top;">0-L</td><td style="vertical-align: top;"><strong>P</strong></td><td style="vertical-align: top;">perkutan (Teletherapie)</td><td style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td style="vertical-align: top;"></td></tr><tr><td style="vertical-align: top;">0-L</td><td style="vertical-align: top;"><strong>PRCJ</strong></td><td style="vertical-align: top;">Radiochemotherapie/Sensitizer: ja</td><td style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td style="vertical-align: top;"></td></tr><tr><td style="vertical-align: top;">0-L</td><td style="vertical-align: top;"><strong>PRCN</strong></td><td style="vertical-align: top;">Radiochemotherapie/Sensitizer: nein</td><td style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td style="vertical-align: top;"></td></tr><tr><td style="vertical-align: top;">0-L</td><td style="vertical-align: top;"><strong>K</strong></td><td style="vertical-align: top;">endokavitäre Kontakttherapie (Brachytherapie)</td><td style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td style="vertical-align: top;"></td></tr><tr><td style="vertical-align: top;">0-L</td><td style="vertical-align: top;"><strong>KHDR</strong></td><td style="vertical-align: top;">K + high dose rate therapy</td><td style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td style="vertical-align: top;"></td></tr><tr><td style="vertical-align: top;">0-L</td><td style="vertical-align: top;"><strong>KPDR</strong></td><td style="vertical-align: top;">K + pulsed dose rate therapy</td><td style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td style="vertical-align: top;"></td></tr><tr><td style="vertical-align: top;">0-L</td><td style="vertical-align: top;"><strong>KLDR</strong></td><td style="vertical-align: top;">K + low dose rate therapy</td><td style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td style="vertical-align: top;"></td></tr><tr><td style="vertical-align: top;">0-L</td><td style="vertical-align: top;"><strong>I</strong></td><td style="vertical-align: top;">interstitielle Kontakttherapie (Brachytherapie)</td><td style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td style="vertical-align: top;"></td></tr><tr><td style="vertical-align: top;">0-L</td><td style="vertical-align: top;"><strong>IHDR</strong></td><td style="vertical-align: top;">I + high dose rate therapy</td><td style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td style="vertical-align: top;"></td></tr><tr><td style="vertical-align: top;">0-L</td><td style="vertical-align: top;"><strong>IPDR</strong></td><td style="vertical-align: top;">I + pulsed dose rate therapy</td><td style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td style="vertical-align: top;"></td></tr><tr><td style="vertical-align: top;">0-L</td><td style="vertical-align: top;"><strong>ILDR</strong></td><td style="vertical-align: top;">I + low dose rate therapy</td><td style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td style="vertical-align: top;"></td></tr><tr><td style="vertical-align: top;">0-L</td><td style="vertical-align: top;"><strong>M</strong></td><td style="vertical-align: top;">metabolische Therapie (Radionuklide)</td><td style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td style="vertical-align: top;"></td></tr><tr><td style="vertical-align: top;">0-L</td><td style="vertical-align: top;"><strong>MSIRT</strong></td><td style="vertical-align: top;">M + Selektive Interne Radio-Therapie</td><td style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td style="vertical-align: top;"></td></tr><tr><td style="vertical-align: top;">0-L</td><td style="vertical-align: top;"><strong>MPRRT</strong></td><td style="vertical-align: top;">M + Peptid-Radio-Rezeptor-Therapie</td><td style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td style="vertical-align: top;"></td></tr><tr><td style="vertical-align: top;">0-L</td><td style="vertical-align: top;"><strong>S</strong></td><td style="vertical-align: top;">Sonstiges</td><td style="vertical-align: top;">1.2.276.0.76.3.1.131.1.5.132</td><td style="vertical-align: top;"></td></tr></table></td></tr><tr class="desclabel"><td colspan="4">Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors werden im @nullFlavor Attribut statt in @code angegeben.</td></tr></table></td></tr></table>

Aktuelle Version vom 10. Juni 2016, 11:18 Uhr

Beschreibung
Applikationsart
Value Set NameValue Set IdVersion / EingangsdatumStatus
ApplArt1.2.276.0.76.3.1.131.1.11.1322015‑12‑08Entwurf
Quell-Codesystem:
  • 1.2.276.0.76.3.1.131.1.5.132
Level/ TypCodeAnzeigenameCodesystemBeschreibung
0-LPperkutan (Teletherapie)1.2.276.0.76.3.1.131.1.5.132
0-LPRCJRadiochemotherapie/Sensitizer: ja1.2.276.0.76.3.1.131.1.5.132
0-LPRCNRadiochemotherapie/Sensitizer: nein1.2.276.0.76.3.1.131.1.5.132
0-LKendokavitäre Kontakttherapie (Brachytherapie)1.2.276.0.76.3.1.131.1.5.132
0-LKHDRK + high dose rate therapy1.2.276.0.76.3.1.131.1.5.132
0-LKPDRK + pulsed dose rate therapy1.2.276.0.76.3.1.131.1.5.132
0-LKLDRK + low dose rate therapy1.2.276.0.76.3.1.131.1.5.132
0-LIinterstitielle Kontakttherapie (Brachytherapie)1.2.276.0.76.3.1.131.1.5.132
0-LIHDRI + high dose rate therapy1.2.276.0.76.3.1.131.1.5.132
0-LIPDRI + pulsed dose rate therapy1.2.276.0.76.3.1.131.1.5.132
0-LILDRI + low dose rate therapy1.2.276.0.76.3.1.131.1.5.132
0-LMmetabolische Therapie (Radionuklide)1.2.276.0.76.3.1.131.1.5.132
0-LMSIRTM + Selektive Interne Radio-Therapie1.2.276.0.76.3.1.131.1.5.132
0-LMPRRTM + Peptid-Radio-Rezeptor-Therapie1.2.276.0.76.3.1.131.1.5.132
0-LSSonstiges1.2.276.0.76.3.1.131.1.5.132
Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors werden im @nullFlavor Attribut statt in @code angegeben.